2026-03-17 • clinicaltrialvanguard.com
BBP-418 Demonstrates Effectiveness and Safety During Phase 3 LGMD2I/R9 Trial
2026-03-17 • clinicaltrialvanguard.com
BBP-418 Demonstrates Effectiveness and Safety During Phase 3 LGMD2I/R9 Trial2026-03-13 • quiverquant.com
BridgeBio Pharma Shows Positive Interim Phase 3 FORTIFY Data for BBP-418 in LGMD2I/R9 Presented at MDA Conference2026-03-06 • geneonline.com
BridgeBio Pharma will showcase Phase 3 FORTIFY Trial results for the LGMD2I/R9 treatment during the 2026 MDA Conference.2026-03-05 • manilatimes.net
BridgeBio will share further results from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical and Scientific Conference14 minutes ago • prnewswire.co.uk
Fortrade Tracks Energy Market Volatility as Geopolitical Risks Influence Global Markets44 minutes ago • prnewswire.co.uk
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress44 minutes ago • prnewswire.co.uk
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial6 hours ago • prnewswire.co.uk
Deye’s 2026 Frankfurt Distributor and Partner Summit Ended Positively2026-03-21 • prnewswire.co.uk
Shareholder Lawsuit Filed Against Goeasy Ltd.28 minutes ago • EIN Presswire
Hughey Law Firm Surpasses $300 Million in Verdicts & Settlements, Nearly Half Recovered for Elder Abuse Injury Victims28 minutes ago • EIN Presswire
Premiere Screening of 'Love in Storytown' Comes to Historic Jackson Theatre on April 1228 minutes ago • EIN Presswire
Property Trade Network Launches Cash Offer Platform for Home Sellers14 minutes ago • prnewswire.co.uk
Fortrade Tracks Energy Market Volatility as Geopolitical Risks Influence Global Markets14 minutes ago • prnewswire.co.uk
Propel taps investors in £306m debut issueStay ahead with real-time headlines from top sources, categorized by sector and country.